Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Longeveron LLC

LGVN
Current price
2.17 USD -0.03 USD (-1.36%)
Last closed 2.2 USD
ISIN US54303L1044
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 31 590 900 USD
Yield for 12 month -87.94 %
1Y
3Y
5Y
10Y
15Y
LGVN
21.11.2021 - 28.11.2021

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida. Address: Life Science & Technology Park, Miami, FL, United States, 33136

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.5 USD

P/E ratio

Dividend Yield

Current Year

+709 000 USD

Last Year

+1 222 000 USD

Current Quarter

+468 000 USD

Last Quarter

+548 000 USD

Current Year

-725 000 USD

Last Year

+497 000 USD

Current Quarter

+115 000 USD

Last Quarter

+76 000 USD

Key Figures LGVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -17 219 000 USD
Operating Margin TTM -747.86 %
PE Ratio
Return On Assets TTM -62.24 %
PEG Ratio
Return On Equity TTM -142.16 %
Wall Street Target Price 8.5 USD
Revenue TTM 1 229 000 USD
Book Value 1.55 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 115.7 %
Dividend Yield
Gross Profit TTM 497 000 USD
Earnings per share -8.86 USD
Diluted Eps TTM -8.86 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics LGVN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History LGVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 27.03.2024
Dividend Date

Stock Valuation LGVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 17.0576
Price Sales TTM 25.7046
Enterprise Value EBITDA -49.6146
Price Book MRQ 2.1186

Financials LGVN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators LGVN

For 52 weeks

0.77 USD 23.9 USD
50 Day MA 2.03 USD
Shares Short Prior Month 749 645
200 Day MA 2.77 USD
Short Ratio 1.46
Shares Short 593 913
Short Percent 4.76 %